Drug-excipient interaction and its importance in dosage form development: A review study
Keywords:
Excipient, Drug InteractionAbstract
Excipients are included in dosage forms to aid manufacture, administration or absorption. Although considered pharmacologically inert, excipients can initiate, propagate or participate in chemical or physical interactions with drug compounds, which may compromise the effectiveness of a medication. Exicipients are not exquisitely pure. Even for the most commonly used excipients, it is necessary to understand the context of their manufacture in order to identify potential active pharmaceutical ingredients interactions with trace components. Chemical interactions can lead to degradation of the active ingredient, thereby reducing the amount available for therapeutic effect. Physical interactions can affect rate of dissolution, uniformity of dose or ease of administration.
References
Aidrian J. (1982). The Maillard Reaction. In M. Rechcigl (Ed.) Handbook of the Nutritive Value of Processed Food, Vol. 1 (pp 529-608). Boca Raton, Florida, USA.
Almond HR., Janicki CA., Jr. Reaction of Haloperidol with 5 (Hydroxymethyl)-2-Furfuraldehyde, an Impurity in Anhydrous Lactose. J. Pharm. Sci. 1974; 63: 41–43.
Azaz E., Donbrow M., Pillersdorf AM. Autoxidation of Polysorbates. J. Pharm.Sci. 1978; 67(12): 1676–1681.
Baertschi SW, Johnson RA, Wirth DD, et al. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. J Pharm Sci 1998; 87(1): 31-39
Baertschi SW., Gregg SM., Hallenbeck DK., Johnson RA., Maple SR., Miller MS., Wirth DD. Maillard reaction of lactose and fluoxetine hydrochloride, a secondry amine. J.Pharm, Sci.1998; 87: 31-39
Bates TR., Dixon E., Nightingale CH. Kinetics of Hydrolysis of Polyoxy-ethylene (20) Sorbitan Fatty Acid Ester Surfactants. J. Pharm. Pharmacol. 1973; 25(6): 470-477.
Bhatia VN., Benet LZ., Guillory JK., Singh P., Sokoloski TD. Effectof inert tablet ingredients on drug absorption. I. effect of PEG 4000 on intestinal absorption of four barbiturates. J. Pharm. Sci. 1996; 55:63-68. Bhattacharya L. Excipients quality in Pharmaceutical development: Understanding their function benefits process control. Contract pharma, article, June 2006.
Blecher L. Excipients-the important components. Pharm process.1995; 12(1): 6-7.
Block LH., Pankaj Reg, Sabnis S. Use of chitosan in compressed tablets of Diclofenac sodium: inhibition of drug release in an acidic environment. Pharm. Dev. Technol. 1997; 2: 243–255.
Brownley CA., Jr, Lachman L. Browning of Spray-Processed Lactose. J. Pharm. Sci. 1964; 53: 452–454.
Brownley CA., Jr, Lachman L. Preliminary Report on the Comparative Stability of Certified Colorants with Lactose in Aqueous Solution. J. Pharm. Sci. 1963; 52: 8–93.
Bundgaard H. Polymerization of Penicillins: Kinetics and Mechanism of Di- and Polymerizatio of Ampicillin in Aqueous Solution. Acta Pharma. Suec. 1976; 13(1): 9–26.
Cavatur R., Chrzan Z., Vemuri NM. Use of isothermal microcalorimetry in pharmaceutical Preformulation studies Part III. Evaluation of excipients compatibility of a new chemical entity. J Therm Anal Cal. 2004; 78: 63-72. Crowley PJ and Martini LG. Excipients in Pharmaceutical Products: Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker Inc.
